Tumors

Good dogs: The list

2011-07-18 00:00:00

They're more than man's best friends: They're friends with benefits. Here are a few ways dogs are helping to make our lives healthier, safer and longer. Search and rescue: When disaster strikes, search-and-rescue dogs are never far behind. After the...

Cellphones, kids and cancer: Don't worry, be happy?

2011-07-28 11:49:00

The first-ever study comparing brain cancer incidence in kids who use cellphones with those who do not has found no difference, suggesting that children's long-feared vulnerability to brain cancer with early cellphone use does not exist. In a four-...

Baruj Benacerraf dies at 90; Nobelist made key discoveries about immune system

2011-08-07 00:00:00

Dr. Baruj Benacerraf, who shared the 1980 Nobel Prize in physiology or medicine for his pioneering work explaining why some people are able to fight off infections and tumors while others are not, died Tuesday at his Boston home. He was 90. The cause was...

Test linked to fewer colorectal cancer deaths

2010-04-27 19:04:00

A single sigmoidoscopy between ages 55 and 64 can reduce deaths from colorectal cancer by at least 43%, British researchers reported Tuesday. The results from the first large randomized trial of sigmoidoscopy show that it is a more effective tool than...

A cancer cocktail's edge

2009-07-06 00:00:00

Even if a vaccine produces an appropriate cancer-attacking immune response, it still may not be enough to achieve clinical benefit, especially in patients with very advanced disease. This could be because the ability of large tumors to suppress the...

Coming soon in the medical arsenal against cancer: vaccines

2009-07-06 00:00:00

It's a deceptively simple idea: What if doctors could recruit the body's own immune system to fight cancer? The complexities of the immune system have kept this from becoming reality, until now. Three cancer vaccines -- for prostate cancer, melanoma and...

FDA approves first oral drug to slow multiple sclerosis progression

2010-09-22 12:04:00

A failed anti-rejection drug got a new purpose and a new lease on commercial life Wednesday as the Food and Drug Administration approved the medication fingolimod -- to be marketed as Gilenya -- to slow the progression of disability in multiple...

Cancer screening: What could it hurt? A lot, actually

2009-11-21 00:00:00

It seemed like a good idea at the time. In 1984, Japan began screening the urine of 6-month-old infants for neuroblastoma, the most common type of solid tumor in young children. The test was simple and could show signs of cancer long before clinical...

Many men with low-risk prostate cancer overtreated, study finds

2010-07-27 09:39:00

About three-quarters of men with low-risk prostate tumors that can safely be ignored for months or years receive aggressive treatment, despite the risk of complications, researchers reported Monday. The findings, published in the Archives of Internal...

Therapies' benefits unclear

2010-01-18 00:00:00

In a quest to look younger, be healthier and feel more vital later in life, increasing numbers of men, just like Jeffry Life, are turning to testosterone and human growth hormone. Use of both hormones is controversial. Read on: Testosterone: "Older men ....

Grant money could speed stem cell cures

2010-01-10 00:00:00

Dr. Karen Aboody estimates that she has cured several hundred mice of a cancer of the central nervous system called neuroblastoma. First she injected them with specialized neural stem cells that naturally zero in on the tumors and surround them. Then she...

Junipero Serra needs just one more miracle

2009-08-28 00:00:00

In a basement at Old Mission Santa Barbara, a filing cabinet is thick with claims of miracles that didn't make the grade. A man falls off his horse and, thanks to Junipero Serra, he gets up unscathed. A woman visits Serra's tomb in Carmel and something...

Christian Stilwell, 17, of Algonquin, who died in his sleep in April, had a cystic lesion on his brain that had gone undetected. It is unknown whether the lesion was related to his migraines.

2011-06-13 14:30:13

Exemestane, sold as Aromasin, can reduce the risk of tumors in high- and moderate-risk post-menopausal women by 65% over a three-year period, researchers reported June 4 in the New England Journal of Medicine.

2011-06-10 12:08:39

PLX4032, or vemurafenib, is the first chemotherapy agent directed at a specific mutation involved in the formation of skin tumors , which occurs in about half of melanoma patients. Ipilimumab, marketed as Yervoy, stimulates the immune system to fight tumors, and has proven to be more effective than

2011-06-10 11:13:22